Table 1 Characteristics of 234 patients with cancer and IPE
From: Prognostic assessment for patients with cancer and incidental pulmonary embolism
% (n)+ | |
|---|---|
Age | |
[Median: 67 (Range: 27–91)] | |
Gender | |
Male | 59 (139) |
Female | 41 (95) |
Setting | |
Radical/adjuvant | 20 (46) |
Metastatic/incurable | 80 (188) |
Diagnosis | |
Colorectal cancer, early | 5 (12) |
Colorectal cancer, metastatic | 20 (46) |
Oesophagogastric Cancer, early | 7 (17) |
Oesophagogastric Cancer, metastatic | 9 (21) |
Breast Cancer, Metastatic | 9 (21) |
Pancreaticobiliary Cancer, Advanced | 9 (21) |
NSCLC Metastatic/ SCLC * | 12 (28) |
Other | 29 (68) |
Treatment | |
Cytotoxic chemotherapy | 66 (154) |
Biologic/targeted therapy ** | 13 (30) |
Hormonal manipulation therapy*** | 4 (10) |
Interferon | 1 (2) |
Risk Factors for VTE | |
Recent (30d) hospitalisation | 15 (36) |
Recent (30d) Surgery | 2 (5) |
Indwelling CVC | 15 (35) |
PS | |
0 | 45 (105) |
1/2 | 43 (100) |
3/4 | 10 (23) |
MD | 3 (6) |
Extent of IPE | |
Bilateral | 39 (91) |
Largest vessel: pulmonary artery (main, right, left) | 20 (46) |
Largest vessel: lobar branch(es) | 27 (63) |
Largest vessel: segmental or subsegmental | 42 (99) |
Largest vessel: subsegmental branches | 11 (25) |
Symptoms (self reported) | |
Any new symptom | 42 (98) |
Worsening pre-existing symptoms | 21 (49) |
PESI group | |
I/II | 12 (29) |
III | 42 (99) |
IV | 37 (86) |
V | 8 (20) |